122 related articles for article (PubMed ID: 17119107)
1. Efficacy with high-dose aripiprazole after olanzapine-related metabolic disturbances.
Chavez B; Poveda RA
Ann Pharmacother; 2006 Dec; 40(12):2265-8. PubMed ID: 17119107
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive effects of aripiprazole on metabolic profiles: comparison of patients treated with olanzapine to patients treated with other atypical antipsychotic drugs.
Wang LJ; Ree SC; Huang YS; Hsiao CC; Chen CK
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():260-6. PubMed ID: 23085073
[TBL] [Abstract][Full Text] [Related]
3. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH
J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384
[TBL] [Abstract][Full Text] [Related]
4. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder post hoc analyses of 3 randomized, controlled clinical trials.
Hoffmann VP; Case M; Stauffer VL; Jacobson JG; Conley RR
J Clin Psychopharmacol; 2010 Dec; 30(6):656-60. PubMed ID: 21105275
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of aripiprazole for the treatment of schizophrenia: what dose is required?].
Charpeaud T; Samalin L; Llorca PM
Encephale; 2014 Feb; 40(1):62-73. PubMed ID: 24445245
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of high-dose aripiprazole for treatment-resistant schizoaffective disorder: a case report.
Saatcioglu O; Gumus S; Kamberyan K; Yanik M
Psychopharmacol Bull; 2010; 43(4):70-2. PubMed ID: 21240152
[TBL] [Abstract][Full Text] [Related]
8. Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients.
Chen CH; Huang MC; Lu ML
J Clin Psychopharmacol; 2007 Oct; 27(5):516-7. PubMed ID: 17873689
[No Abstract] [Full Text] [Related]
9. Metabolic effects and cost-effectiveness of aripiprazole versus olanzapine in schizophrenia and bipolar disorder.
Kasteng F; Eriksson J; Sennfält K; Lindgren P
Acta Psychiatr Scand; 2011 Sep; 124(3):214-25. PubMed ID: 21609324
[TBL] [Abstract][Full Text] [Related]
10. Strategies for transitioning therapy to aripiprazole from other antipsychotics in schizophrenia.
Wisniewski CS; Robert S
Ann Pharmacother; 2012; 46(7-8):1097-104. PubMed ID: 22811346
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Stip E; Tourjman V
Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
[TBL] [Abstract][Full Text] [Related]
12. Aripiprazole: new drug. Just another neuroleptic.
Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine-induced triglyceride and aminotransferase elevations without weight gain or hyperglycemia normalized after switching to aripiprazole.
Pawelczyk T; Pawelczyk A; Rabe-Jablonska J
J Psychiatr Pract; 2014 Jul; 20(4):301-7. PubMed ID: 25036587
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia.
McEvoy JP; Daniel DG; Carson WH; McQuade RD; Marcus RN
J Psychiatr Res; 2007 Dec; 41(11):895-905. PubMed ID: 17631314
[TBL] [Abstract][Full Text] [Related]
15. Switching and combining antipsychotics.
Correll CU
CNS Spectr; 2010 Apr; 15(4 Suppl 6):8-11. PubMed ID: 21141654
[No Abstract] [Full Text] [Related]
16. Aripiprazole for the management of olanzapine-induced weight gain.
Englisch S; Weinbrenner A; Inta D; Zink M
Pharmacopsychiatry; 2009 Jul; 42(4):166-7. PubMed ID: 19585397
[No Abstract] [Full Text] [Related]
17. Aripirazole-olanzapine combination for treatment of schizophrenia.
Duggal HS
Can J Psychiatry; 2004 Feb; 49(2):151. PubMed ID: 15065751
[No Abstract] [Full Text] [Related]
18. Combination loxapine and aripiprazole for refractory hallucinations in schizophrenia.
Sokolski KN
Ann Pharmacother; 2011 Jul; 45(7-8):e36. PubMed ID: 21672885
[TBL] [Abstract][Full Text] [Related]
19. Dramatic Weight Loss Following Addition of Aripiprazole to Olanzapine in a Patient With Treatment-resistant Schizophrenia: A Case Report.
Boland X; Chhabra P
J Psychiatr Pract; 2019 Mar; 25(2):135-138. PubMed ID: 30849062
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophrenia.
Kim SW; Shin IS; Kim JM; Lee JH; Lee YH; Yang SJ; Yoon JS
Clin Neuropharmacol; 2009; 32(5):243-9. PubMed ID: 19620849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]